טוען...
Targeting Nuclear Export Proteins in Multiple Myeloma Therapy
Multiple myeloma (MM) is an incurable malignancy of plasma cells with a clinical course characterized by multiple relapses and treatment refractoriness. While recent treatment advancements have extended overall survival (OS), refractory MM has a poor prognosis, with a median OS of between 4 and 6 mo...
שמור ב:
| הוצא לאור ב: | Target Oncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7570401/ https://ncbi.nlm.nih.gov/pubmed/33074469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-020-00758-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|